2. Academic Validation
  3. Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses

Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses

  • Antiviral Res. 2020 Jun;178:104805. doi: 10.1016/j.antiviral.2020.104805.
Mike Bray,  Craig Rayner,  François Noël,  David Jans,  Kylie Wagstaff
PMID: 32330482 DOI: 10.1016/j.antiviral.2020.104805
Figures
Products